Back to search
Non-Diabetic Disorder of Endocrine Pancreas
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Diabetic Disorder of Endocrine Pancreas trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Diabetic Disorder of Endocrine Pancreas trials you may qualify forThe purpose of this investigation is to assess the role of melatonin receptor 1B (MTNR1B) single nucleotide polymorphism (SNP)\*food timing interaction on gluco…
Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells are destroyed, resulting in poor blood sugar control. The purpose…
Use of CGM to determine diagnosis in possible spontaneous or reactive hypoglycaemia. Use of CGM to aid treatment optimisation in spontaneous or reactive hypogl…
Current guidelines on the diagnoses and management of cystic fibrosis (CF) related diabetes recommend treatment for diabetes based on diagnostic criteria derive…
This study is designed to evaluate the tolerability of Myfortic®/Simulect® combination in diabetic patients in a steroid free regimen. Due to the diverse ethnic…
The purpose of this investigation is to assess in a community-based cohort of late-night eaters the effect of coincident food intake and endogenous melatonin on…
Under chronic immunosuppressive and corticosteroid therapy, transplant patients have a tendency to develop in the long-term diabetes. Patients who have received…
The present proof of concept study addresses the following specific aims: The general objectives of this work are: 1. To increase and maintain the functional…